Select Page




Get the Latest Updates

Beware the Lady Killer

February is a month that’s all about the heart. No, not just Valentine’s Day. I’m talking about American Heart Month. Not too long ago it was thought that heart disease was a problem for men. Warnings for men to recognize chest pain and left arm pain helped educate us...

read more

Obesity Costs the World $2 Trillion

Obesity continues to garner significant attention, both in the medical community and in the media. That’s no surprise because the problem isn’t going away, and in fact continues to worsen. It’s estimated that half of the world population will be obese by 2030 if the...

read more

A Glimpse into the Future of Pharmacy Benefits

It’s no secret that the costs for prescription drugs are skyrocketing. What’s interesting (and disheartening) is that costs are increasing rapidly whether we’re talking about new drugs being introduced into the marketplace (think $85,000-100,000 to treat hepatitis C)...

read more

The Hep C Drug Field Narrows

Today Bristol-Myers Squibb announced their decision to pull out of the hepatitis C drug race. We were expecting to see a combination therapy from Bristol-Myers in December or early 2015. Gilead, the manufacturer of Sovaldi and another Sovaldi combination therapy...

read more

Another Generic Medication Pricing “Gotcha”

As I described in a recent blog post (Peeking Behind the Curtain of Generic Medications), generic medications are not automatically less expensive than their brand equivalents. When a new generic drug is launched, there’s a period of exclusivity during which prices...

read more